Back to Search
Start Over
Supplementary Figure 4 from Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 37K, Supplemental Fig. S4. The effect of baseline IGF and IGF-related protein expression on overall survival.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....7fa54745b1bd504f4572d41f9069c652
- Full Text :
- https://doi.org/10.1158/1078-0432.22447461.v1